Evidence map›Paper›PMID 36172401›Full record

ArticlePharmacogenomics and personalized medicine2022

Contribution of

Shuyong Yu, Guihong Yuan, Feixiang Hu, Yongyu Li, Zhuang Chen, Ronglin Zhang, Ping Li, Zhaowei Chen, Jian Song

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shuyong Yu *Department of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Guihong Yuan *Department of Gastroenterology, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Feixiang Hu *Department of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Yongyu LiDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Zhuang ChenDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Ronglin ZhangDigestive Endoscopy Center, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Ping LiDigestive Endoscopy Center, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Zhaowei ChenDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, 570100, People's Republic of China.
Jian SongDepartment of Gastroenterology, Southern University of Science and Technology Hospital, Shenzhen, 518000, People's Republic of China.ORCID 0000-0001-5345-3909
Haikou City People's Hospital · CNHainan General Hospital · CNHainan Medical College Hospital · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Four single nucleotide polymorphisms (SNPs) in Results: Rs10934270 was associated with lower EC susceptibility (OR = 0.64, Conclusion: Our research is the first to report that

Indexed as

esophageal cancerFPRP analysisgenetic polymorphismsgenotype–phenotype analysesZBTB20

Identifiers

PMID36172401
PMCPMC9512063
OpenAlexW4296480505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.